Sino Biological,Inc. (SHE:301047)

China · Delayed Price · Currency is CNY

99.63

+6.32 (6.77%)

At close: Sep 8, 2026

Market Cap	12.12B +22.4%
Revenue (ttm)	768.00M +21.4%
Net Income	165.24M +39.2%
EPS	1.36 +42.6%
Shares Out	121.64M
PE Ratio	73.34
Forward PE	59.66
Dividend	5.20 (5.50%)
Ex-Dividend Date	May 15, 2026

Volume	11,502,592
Open	93.17
Previous Close	93.31
Day's Range	91.28 - 104.00
52-Week Range	58.05 - 139.49
Beta	0.76
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Sino Biological,Inc.

Sino Biological,Inc. engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, in... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2016

Employees 1,069

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301047

Full Company Profile

Financial Performance

In 2025, Sino Biological,Inc.'s revenue was 699.56 million, an increase of 14.00% compared to the previous year's 613.67 million. Earnings were 147.74 million, an increase of 21.17%.

Financial Statements